Top compounds associated with response to RGPD4


Feature Type Standardized
Nominal ANOVA
mRNA paclitaxel UHNBreast pan-cancer AAC -0.61 0.03
mRNA lapatinib UHNBreast pan-cancer AAC -0.39 0.2
mRNA Erlotinib UHNBreast pan-cancer AAC -0.16 0.6
mRNA BRD9876:MK-1775 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.16 0.1
mRNA BRD-K01737880 CTRPv2 pan-cancer AAC -0.13 0.2
mRNA AZD6244 UHNBreast pan-cancer AAC -0.12 0.7
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.002
mRNA GSK1120212 CTRPv2 pan-cancer AAC -0.11 0.03
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.098 0.004
mRNA Bexarotene CTRPv2 pan-cancer AAC -0.097 0.006
Download CSV